Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4040207

Cc1ccncc1-c1c(Cl)c(C(N)=O)c2n1CCNC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 5/20 0.35
TGFBR1 P36897 3/20 0.35
CYP11B2 P19099 3/20 0.33
LCK P06239 1/20 0.32
BTK Q06187 1/20 0.32
SIRT3 Q9NTG7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ABL1 P00519 1/20 0.32
PTPN11 Q06124 1/20 0.32
SLC22A12 Q96S37 1/20 0.31
ATR Q13535 1/20 0.31
MAP4K1 Q92918 1/20 0.31
SLC2A1 P11166 1/20 0.30
HTR2C P28335 2/20 0.30
HTR2A P28223 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4039701 0.86 CYP11B2 (0.33) ACVR1TGFBR1CYP11B2LCKBTK
Trifluoroacetic Acid SCHEMBL4036264 0.79 HTR2A (0.40) BTKSLC2A1HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL4037873 0.78 HTR2A (0.33) HTR2CHTR2A
SCHEMBL2157416 0.77 CYP11B2 (0.41) CYP11B2LCKBTKSIRT3TDP1
Trifluoroacetic Acid SCHEMBL4036958 0.76 MKNK1 (0.36) ABL1HTR2CHTR2ACYP1A2
SCHEMBL4040261 0.75 MKNK1 (0.42) CYP11B2HTR2CHTR2ACYP1A2
Trifluoroacetic Acid SCHEMBL4036656 0.72 MKNK1 (0.36) CYP11B2TDP1HTR2CHTR2ACYP1A2
SCHEMBL4043737 0.72 NR1H2 (0.39)
Trifluoroacetic Acid SCHEMBL4037121 0.71 CSNK1E (0.33) HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL4043668 0.70 MKNK1 (0.34) HTR2CHTR2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463728-B1 FUSED CYCLIC MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-01-14 EP disclosed
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 EP disclosed
EP-1436291-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS Aventis Pharma S.A. (FR) 2004-07-14 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed